Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-07
Description
The present notice serves to conclude agreements with pharmaceutical companies within the meaning of § 130a para. 8 sentence 1 SGB V. The invitation to participate is addressed only to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs within the meaning of § 4 para. 18 of the German Medicines Act. This is not an Open Procedure according to § 15 VgV in conjunction with § 119 para. 3 GWB, but a publication of the invitation to conclude/join discount contracts with conditions fixed and non-negotiable for all participants, including the amount of the discount. There can be an unlimited number of contractual partners, which can be pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs within the meaning of § 4 para. 18 of the German Medicines Act.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ponesimod, ATC L04AE04
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ebastin, ATC R06AX22
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026
Germany – Devices and instruments for infusion – Infusionstechnik Klinikum Oldenburg
Klinikum Oldenburg AöRGermanyDevices and instruments for infusionDeadline in 28 daysPublished on Sep 20, 2026
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Vaginalring mit Gestagenen und Estrogenen, ATC G02BB01
AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPharmaceutical productsDeadline in 710 daysPublished on Sep 20, 2026